Blog

The potential of incorporating pragmatic elements in oncology clinical trials – Friends of Cancer Research

Photo taken from Friends of Cancer Research/LinkedIn

Sep 7, 2024, 09:09

The potential of incorporating pragmatic elements in oncology clinical trials – Friends of Cancer Research

Friends of Cancer Research shared a post on X:

“New Friends perspective in European Society for Medical Oncology RWD & Digital Health discusses the potential of incorporating pragmatic elements in oncology clinical trials. Pragmatic Trials are a promising way to achieve more efficient, relevant, & patient-centered drug development.“

Bridging research and practice: enhancing regulatory decisions with pragmatic clinical trials in oncology

Authors: M.D. Stewart, A.E. McKee, R.S. Herbst, H.S. Andrews, B.A. McKelvey, E.V. Sigal, J.D. Allen

The potential of incorporating pragmatic elements in oncology clinical trials - Friends of Cancer Research

Source: Friends of Cancer Research/X

A.E. McKee B.A. McKelvey cancer cancer awareness E.V. Sigal ESMO ESMO - European Society for Medical Oncology ESMO24 Friends of Cancer Research H.S. Andrews J.D. Allen M.D. Stewart OncoDaily Oncology R.S. Herbst

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage